Monocyte CD64 Does Not Enhance Neutrophil CD64 As a Diagnostic Marker in Neonatal Sepsis.

Fangyong Li,Veronika Shabanova,Chao Wang,Henry M. Rinder,Vineet Bhandari
DOI: https://doi.org/10.1097/inf.0000000000000411
2014-01-01
Abstract:1100 | www.pidj.com © 2014 Lippincott Williams & Wilkins that mCD64 appeared to have no additional value in predicting culture-proven neonatal sepsis compared with nCD64 measurements. Our results support reports by other investigators where the mCD64 performed on par or below that of nCD64 as a diagnostic marker for neonatal sepsis. We speculate the differences in our results, compared with the earlier study, could be because of the different methodology used for measuring and analyzing mCD64. Our monocyte and neutrophil CD64 values were generated using a different antibody and were derived using an additional isotype control-based index to control for nonspecific fluorescence, often a significant issue for quantitating monocyte surface marker fluorescence. In addition, the differences in the types of microorganisms (which could instigate variable response in the n and/or m CD64 expression) isolated from the neonates at these 2 sites could also be another potential reason for the discrepant results. Additional studies are required to assess the utility, if any, of mCD64 in addition to that of nCD64, in the diagnosis of neonatal sepsis.
What problem does this paper attempt to address?